HAYA Therapeutics
Drug Discovery · Molecular Diagnostics
37 daysTime to fillmedian of 6 closed roles
Data updated Nov 20, 2026Full reportReport a mistake
Facts
as of Nov 20, 2026We are leveraging the power of the dark genome to develop precise and potent RNA therapies for disease driving cell-state reprogramming.
- Employees
- 25US Form 5500 (plan participants) · Dec 2025
- Website
- hayatx.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
People
37 daysTime to fill
25EmployeesUS Form 5500 (plan participants) · Dec 2025
Where the openings areshare of open roles
Products
Products →HAYA Therapeutics has 1 clinical trials on record, 1 under way.
Clinical trials
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
phase 1 · under way · 10 participants · Nonobstructive Hypertrophic Cardiomyopathy
Oct 2026
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
Milestones
Mar 13, 2025
Sep 11, 2024
Sep 4, 2024
Sources: the outlets named on each headline, each story once
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 0 cities in 0 countries.
0Cities
0Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|
Source: office addresses in postings and company registers
